These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Carnitine deficiency, organic acidemias, and Reye's syndrome. Stumpf DA; Parker WD; Angelini C Neurology; 1985 Jul; 35(7):1041-5. PubMed ID: 3892364 [TBL] [Abstract][Full Text] [Related]
50. In vivo proton magnetic resonance spectroscopy in a case of Reye's syndrome. Kreis R; Pfenninger J; Herschkowitz N; Boesch C Intensive Care Med; 1995 Mar; 21(3):266-9. PubMed ID: 7790619 [TBL] [Abstract][Full Text] [Related]
52. Role of dopaminergic and serotonergic neurotransmitters in behavioral alterations observed in rodent model of hepatic encephalopathy. Dhanda S; Sandhir R Behav Brain Res; 2015 Jun; 286():222-35. PubMed ID: 25639545 [TBL] [Abstract][Full Text] [Related]
54. [Reye syndrome: a case study in a Cuban provincial hospital from 1990 to 1996]. Viñas-Machín PL; Núñez-Díaz BC Rev Neurol; 1999 May 16-31; 28(10):959-61. PubMed ID: 10617371 [TBL] [Abstract][Full Text] [Related]
55. Hepatic and encephalopathic components of Reye's syndrome: factor analysis of admission data from 209 patients. Mitchell RA; Partin JC; Partin JS; Ram ML Neurology; 1985 Aug; 35(8):1236-9. PubMed ID: 4022364 [TBL] [Abstract][Full Text] [Related]
58. Quantitative evaluation of the extent of hepatic enzyme changes in Reye syndrome compared with normal liver or with non-Reye liver disorders: objective criteria for animal models. Mitchell RA; Arcinue EL; Partin JC; Partin JS; Ram ML; Chang CH; Smialek J; Sarnaik A Pediatr Res; 1985 Jan; 19(1):19-22. PubMed ID: 3969310 [TBL] [Abstract][Full Text] [Related]
59. [Reye's syndrome. Description of a case focused on the patient's epileptic seizures]. Jiménez-Caballero PE; Montes-Gonzalo MC; Velázquez-Pérez JM Rev Neurol; 2008 Dec 1-15; 47(11):571-4. PubMed ID: 19048536 [TBL] [Abstract][Full Text] [Related]